ARTICLE | Company News
AZ, Champions Oncology partner to develop novel cohorts of PDX models
September 1, 2017 3:12 PM UTC
AstraZeneca plc (LSE:AZN; NYSE:AZN) and Champions Oncology Inc. (NASDAQ:CSBR) partnered to develop two novel cohorts of patient-derived xenograft (PDX) models. AstraZeneca will utilize the models in...
BCIQ Target Profiles